SPDR S&P Pharmaceuticals ETF: (XPH)
(Delayed Data from NYSE) As of Mar 18, 2024 04:00 PM ET
$42.10 USD
-0.52 (-1.22%)
Volume: 9,260
After-Market: $42.20 +0.10 (0.24 %) 7:58 PM ET
ETF Quote Details
Previous Close | 42.62 |
Open | 42.50 |
Bid | 41.16 |
Ask | 42.89 |
Day Low-High | 42.10-42.50 |
52wk Low-High | 34.67-45.62 |
Volume | 9,260 |
NAV (month end) | 44.46 |
Premium (+)/Discount (-) (month end) | -1.84 |
ETF Expense Ratio
Expense Ratio | 0.35% |
Dividend (Yield) | $0.71 (1.68%) |
Issuer | STATE STREET GLOBAL ADVISORS |
Benchmark for XPH
SP PHARMACEUTICALS SELECT INDUSTRY INDEX
The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.
Fund Summary for XPH
SPDR S&P PHARMACEUTICALS ETF
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.